Docetaxel-Induced Supravenous Serpentine Dermatitis: A Case Report and Literature Review

Sataporn Chaiyakul MD1

Affiliation : 1 Department of Medicine, Vachira Phuket Hospital, Phuket, Thailand

The author reported a rare case of 66-year-old man presenting with cutaneous lesion with a red line spreading along the venous path three days after the (cid:976)irst cycle of docetaxel in advanced stage lung cancer. The examination revealed unilateral well- de(cid:976)ined linear, non- blanchable erythematous to violaceous plaques along the super(cid:976)icial venous network of the right foot and then progressed to the right leg and extended above the right knee. A lesional skin biopsy was done and histopathological (cid:976)indings showed super(cid:976)icial interface dermatitis consistent with supravenous serpentine dermatitis. He was treated with topical betamethasone valerate (0.1%) cream twice daily for one week. The skin lesion improved but he still had residual hyperpigmented skin along the super(cid:976)icial venous network. However, there were some limitations of other chemotherapeutic agents, including pemetrexate and targeted therapy, such as the cost, the second cycle of docetaxel was used with more dilution, the extended time of intravenous transfusion, and the saline infusion before and after chemotherapy. This cutaneous side effect did not occur again. The present case report showed the interruption of docetaxel is not indicted when this reaction happens because it is self-limited. Prevention of this eruption can be achieved by extending the time of drug transfusion, and increasing the dilution of chemotherapy and saline infusion before and after chemotherapy.

Keywords : Docetaxel, Supravenous serpentine dermatitis, Lung cancer, Super(cid:976)icial interface dermatitis

All Articles Download

Information

Related Links